Adam Lamble
Pediatric Hematology-Oncology · Seattle, WANPI 1144511080
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Stemline Therapeutics Inc. accounts for 68.9% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $183 and has fallen 78.4% since, to $40 in 2025. That places this record below the midpoint for pediatric hematology-oncology clinicians in WA, where the typical reported total is $450.
Across 7 payments — averaging $79.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stemline Therapeutics Inc.$384
- Jazz Pharmaceuticals Inc.$123
- Novartis$50
Across 71 payments — averaging $23,499 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stemline Therapeutics Inc.$1.5M
- Merck$71K
- Bristol Myers Squibb$36K
- Amgen$30K
- AbbVie$27K
What the payments were for
- Food & beverage$557100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stemline Therapeutics Inc. | 5 | $384 |
| Jazz Pharmaceuticals Inc. | 1 | $123 |
| Novartis | 1 | $50 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$557 in reported general payments places this provider in the 50th percentile of 60 pediatric hematology-oncology providers in Washington.
See all pediatric hematology-oncology providers in Washington →
Other pediatric hematology-oncology in Seattle
- Allison WheelerSeattle$318K
- Rachel RauSeattle$87K
- Paul CarpenterSeattle$40K
- Kasey LegerSeattle$19K
- Douglas HawkinsSeattle$13K
- Rebecca GardnerSeattle$11K
- Michael BenderSeattle$9K
- Navin PintoSeattle$8K
- Whitney EngSeattle$8K
- Kristin MaherSeattle$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.